Alan Colowick - Jun 22, 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Alan Colowick by Georgia Erbez, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Jun 22, 2022
Transactions value $
$39,999
Form type
4
Date filed
6/24/2022, 06:43 PM
Previous filing
May 19, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +10.2K $0.00 10.2K Jun 22, 2022 Common Stock 10.2K $2.01 Direct F1
transaction HARP Director Stock Option (Right to Buy) Award $40K +28.6K $1.40 28.6K Jun 22, 2022 Common Stock 28.6K $2.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
F2 This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $40,000 ("Election Option").
F3 One-half of the Election Option vested and became exercisable on June 22, 2022, and 25% of each Election Option will vest and become exercisable on each of September 30, 2022 and December 31, 2022, subject to the continuous service of the Reporting Person with the Issuer through each vesting date.